BUSINESS

• MTPC to Push Tenelia, Canaglu to Compete in Diabetes Field
  May 9, 2014

• DSP Sales Up 11.5% in FY2013; Latuda, Softer Yen Eclipse Japan Dip
  May 9, 2014

• MTPC Logs 8.4% Net Profit Rise, 1.6% Sales Decline
  May 9, 2014

• Takeda FY2013 Sales Up 8.6% on Buoyant Azilva, Pantoprazole
  May 9, 2014

• Seikagaku to Initiate PII/III Clinical Trial of SI-614 for Treatment of Dry Eye in the US
  May 9, 2014

• PII Study of Transdermal Allergic Rhinitis Treatment Confirms Significant Improvement in Primary Endpoint: Hisamitsu
  May 9, 2014

• Eisai Sets Up Global Oncology and Neurology Business Units Ahead of Schedule
  May 8, 2014

• Eisai Moves to Boost Global Use of Products via Emerging Market Businesses
  May 8, 2014

• Suglat Tops Anterio’s "Mind Share" Ranking in GP Market in March; Xarelto Rises Sharply
  May 8, 2014

• FDA Grants Priority Review to XTANDI for Add’l Indication: Astellas
  May 8, 2014

• Takara Bio Submits IND Application for PII Study of Anticancer Agent HF10 to US FDA
  May 8, 2014

• Drug Information Gained Mostly from Sales Reps, Less from Online Promotion: IMS Survey
  May 8, 2014

• Nitto Denko Moving Ahead at Full Speed in Japan, US to Develop Nucleic Acid Drug as a Potential Cure for Cirrhosis
  May 7, 2014

• Announcement: 1st Annual Real World Data Japan 2014 - Tokyo Marriott Hotel, July 15-16
  May 7, 2014

• Drug Makers’ Plans for MRs Becoming Clearer; Takeda to Bolster Force, Sanofi Making Big Reduction
  May 7, 2014

• Ono, Nissan Chemical End Licensing Deal on Thrombocytopenia Agent
  May 2, 2014

• Otsuka Granted European Approval for Multidrug-Resistant TB Medicine
  May 2, 2014

• Oncolys Obtains Patent on Manufacturing Process for Anti-HIV Drug OBP-601 in Japan
  May 2, 2014

• Nihon Chouzai Pharmaceutical Sales Reach 23,192 Million Yen in FY2013
  May 1, 2014

• AZ Files for Domestic Approval of Bydureon Pen Formulation
  May 1, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 567
• 568
• 569
• 570
• 571
• 572
• 573
• 574
• 575
• …
• Next ›
• 最終 »